XML 57 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
12 Months Ended
Jan. 28, 2023
Income Tax Disclosure [Abstract]  
Schedule of income tax expense (benefit)
Income tax expense (benefit) is summarized as follows (in thousands):
Year Ended
Jan 28, 2023Jan 29, 2022Jan 30, 2021
Federal:   
Current$$149,811 $(2,390)
Deferred10,577 9,859 (5,274)
State:   
Current(1,963)10,433 248 
Deferred85 2,443 (598)
Foreign:   
Current28,844 13,592 8,285 
Deferred(1,049)(112,458)(6,609)
Total$36,502 $73,680 $(6,338)
Schedule of effective income tax rate reconciliation
Actual income tax expense (benefit) differs from expected income tax expense (benefit) obtained by applying the statutory federal income tax rate to earnings before income taxes as follows:
Year Ended
Jan 28, 2023Jan 29, 2022Jan 30, 2021
Computed “expected” tax rate21.0 %21.0 %21.0 %
State taxes, net of federal benefit1.1 %1.6 %1.2 %
Unrecognized tax liabilities (benefits)2.5 %(0.6 %)(6.6 %)
GILTI2.4 %0.6 %— %
Non-deductible permanent differences1.6 %0.6 %0.4 %
Tax Reform - repatriation tax adjustment0.4 %0.2 %— %
Subpart F Income— %4.5 %— %
Non-deductible participation loss— %1.8 %3.6 %
Intra-entity intellectual property transfer tax rate difference1
— %1.6 %— %
SERP/TOLI— %(0.1 %)1.9 %
Foreign derived intangible income2
— %(1.5 %)— %
Share-based compensation(0.2 %)(0.4 %)1.8 %
Prior year income tax adjustments(1.2 %)0.4 %1.3 %
Valuation reserve3
(4.0 %)0.7 %(26.9 %)
Non-U.S. tax expense (benefit) versus U.S. federal statutory tax rate4
(4.8 %)(2.4 %)9.1 %
Other, net(0.4 %)1.0 %0.5 %
Effective income tax rate18.4 %29.0 %7.3 %
______________________________________________________________________
1During fiscal 2022, the Company completed an intra-entity transfer of intellectual property rights from a U.S. entity to a wholly-owned Swiss subsidiary, resulting in an income tax rate difference of $4.0 million as of January 29, 2022. As of January 28, 2023, the updated rate difference is $5.1 million.
2During fiscal 2022, the Company recognized an additional foreign-derived intangible income tax benefits of $37.0 million related to the intra-entity transfer of intellectual property rights.
3Amounts relate primarily to the release of the valuation reserve offset by valuation reserves on net operating losses, other deferred income tax assets arising during the respective period jurisdictions where there have been cumulative net operating losses, limiting the Company’s ability to consider other subjective evidence to continue to recognize the existing deferred income tax assets.
4The jurisdictional location of pre-tax income (loss) may represent a significant component of the Company’s effective income tax rate as earnings (loss) in foreign jurisdictions are taxed at rates different from the U.S. statutory income tax rate. These amounts exclude the impact of net changes in valuation allowances, audit and other adjustments related to the Company’s non-U.S. operations, as they are reported separately in the appropriate corresponding line items.
Schedule of total income tax expense (benefit) allocation Total income tax expense (benefit) is allocated as follows (in thousands):
Year Ended
Jan 28, 2023Jan 29, 2022Jan 30, 2021
Operations$36,502 $73,680 $(6,338)
Stockholders’ equity450 2,264 (1,534)
Convertible debt(6,207)— — 
Total income tax expense (benefit)$30,745 $75,944 $(7,872)
Schedule of tax effects of components of other comprehensive income (loss)
The income tax effects of the components of other comprehensive income (loss) are allocated as follows (in thousands):
Year Ended
Jan 28, 2023Jan 29, 2022Jan 30, 2021
Derivative financial instruments designated as cash flow hedges$(945)$1,627 $(1,387)
Defined benefit plans1,395 637 (147)
Total income tax expense (benefit)$450 $2,264 $(1,534)
Schedule of total earnings before income tax expense and noncontrolling interest
Total earnings (loss) before income tax expense (benefit) and noncontrolling interests are comprised as follows (in thousands):
Year Ended
Jan 28, 2023Jan 29, 2022Jan 30, 2021
Domestic operations$45,317 $141,920 $(27,984)
Foreign operations152,729 111,809 (59,095)
Earnings (loss) before income tax expense (benefit) and noncontrolling interests$198,046 $253,729 $(87,079)
Schedule of tax effects of temporary differences
The income tax effects of temporary differences that give rise to significant portions of deferred income tax assets and liabilities are as follows (in thousands):
Jan 28, 2023Jan 29, 2022
Deferred income tax assets:  
Operating lease liabilities$156,234 $169,771 
Intangible assets95,119 109,887 
Net operating losses45,384 38,583 
Defined benefit plans10,186 11,762 
Deferred compensation7,177 7,632 
Deferred income5,076 5,771 
Inventory valuation4,025 1,679 
Convertible senior notes hedge transactions3,919 6,884 
Goodwill amortization2,019 4,657 
Sales return and other reserves1,615 2,710 
Account receivable reserve1,454 1,780 
Lease incentives1,438 1,918 
Accrued bonus1,046 2,575 
Uniform capitalization919 1,004 
Excess of financial accounting over tax depreciation/amortization649 1,784 
Other, net13,449 13,826 
Total deferred income tax assets349,709 382,223 
Deferred income tax liabilities:  
Operating right-of-use assets(146,243)(155,618)
Convertible senior notes debt discount— (6,207)
Valuation allowances(45,063)(55,278)
Net deferred income tax assets$158,403 $165,120 
Schedule of reconciliation of unrecognized tax benefit
A reconciliation of the beginning and ending amount of gross unrecognized income tax benefit (excluding interest and penalties) is as follows (in thousands):
Year Ended
Jan 28, 2023Jan 29, 2022Jan 30, 2021
Beginning balance$51,736 $34,246 $29,183 
Additions:
Income tax positions related to the prior year3,954 280 110 
Income tax positions related to the current year454 21,616 8,204 
Reductions:
Income tax positions related to the prior year(70)(2,405)(3,251)
Income tax positions related to the current year— (2,001)— 
Foreign currency translation— — — 
Ending balance$56,074 $51,736 $34,246